Selected research
Market Structure
Global Medical Liquid Embolic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Liquid Embolic Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medical Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Liquid Embolic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Liquid Embolic Agents include BlackSwan Vascular, Success Bio-Tech, Johnson & Johnson, Medtronic, Meril Life and Balt Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Medical Liquid Embolic Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Liquid Embolic Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Liquid Embolic Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Liquid Embolic Agents market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Liquid Embolic Agents Segment by Company
BlackSwan Vascular
Success Bio-Tech
Johnson & Johnson
Medtronic
Meril Life
Balt Group
Medical Liquid Embolic Agents Segment by Type
EVOH-Based
Diluted Cyanoacrylate
Others
Medical Liquid Embolic Agents Segment by Application
Brain Arterio-Venous Malformations (bAVM)
Tumor Embolization
Others
Medical Liquid Embolic Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Liquid Embolic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Liquid Embolic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Liquid Embolic Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Liquid Embolic Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Liquid Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Liquid Embolic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Medical Liquid Embolic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- EVOH-Based
- Diluted Cyanoacrylate
- Others
Applications
- Brain Arterio-Venous Malformations (bAVM)
- Tumor Embolization
- Others
Companies covered
- BlackSwan Vascular
- Success Bio-Tech
- Johnson & Johnson
- Medtronic
- Meril Life
- Balt Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Liquid Embolic Agents Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Liquid Embolic Agents Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Medical Liquid Embolic Agents Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Medical Liquid Embolic Agents Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Medical Liquid Embolic Agents Market Dynamics
- 2.1 Medical Liquid Embolic Agents Industry Trends
- 2.2 Medical Liquid Embolic Agents Industry Drivers
- 2.3 Medical Liquid Embolic Agents Industry Opportunities and Challenges
- 2.4 Medical Liquid Embolic Agents Industry Restraints
3 Medical Liquid Embolic Agents Market by Manufacturers
- 3.1 Global Medical Liquid Embolic Agents Revenue by Manufacturers (2021-2026)
- 3.2 Global Medical Liquid Embolic Agents Sales by Manufacturers (2021-2026)
- 3.3 Global Medical Liquid Embolic Agents Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Medical Liquid Embolic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Liquid Embolic Agents Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Liquid Embolic Agents Manufacturers, Product Type & Application
- 3.7 Global Medical Liquid Embolic Agents Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Liquid Embolic Agents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Liquid Embolic Agents Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Liquid Embolic Agents Tier 1, Tier 2, and Tier 3
4 Medical Liquid Embolic Agents Market by Type
- 4.1 Medical Liquid Embolic Agents Type Introduction
- 4.1.1 EVOH-Based
- 4.1.2 Diluted Cyanoacrylate
- 4.1.3 Others
- 4.2 Global Medical Liquid Embolic Agents Sales by Type
- 4.2.1 Global Medical Liquid Embolic Agents Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Liquid Embolic Agents Sales by Type (2021-2032)
- 4.2.3 Global Medical Liquid Embolic Agents Sales Market Share by Type (2021-2032)
- 4.3 Global Medical Liquid Embolic Agents Revenue by Type
- 4.3.1 Global Medical Liquid Embolic Agents Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Liquid Embolic Agents Revenue by Type (2021-2032)
- 4.3.3 Global Medical Liquid Embolic Agents Revenue Market Share by Type (2021-2032)
5 Medical Liquid Embolic Agents Market by Application
- 5.1 Medical Liquid Embolic Agents Application Introduction
- 5.1.1 Brain Arterio-Venous Malformations (bAVM)
- 5.1.2 Tumor Embolization
- 5.1.3 Others
- 5.2 Global Medical Liquid Embolic Agents Sales by Application
- 5.2.1 Global Medical Liquid Embolic Agents Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Liquid Embolic Agents Sales by Application (2021-2032)
- 5.2.3 Global Medical Liquid Embolic Agents Sales Market Share by Application (2021-2032)
- 5.3 Global Medical Liquid Embolic Agents Revenue by Application
- 5.3.1 Global Medical Liquid Embolic Agents Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Liquid Embolic Agents Revenue by Application (2021-2032)
- 5.3.3 Global Medical Liquid Embolic Agents Revenue Market Share by Application (2021-2032)
6 Global Medical Liquid Embolic Agents Sales by Region
- 6.1 Global Medical Liquid Embolic Agents Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Liquid Embolic Agents Sales by Region (2021-2032)
- 6.2.1 Global Medical Liquid Embolic Agents Sales by Region (2021-2026)
- 6.2.2 Global Medical Liquid Embolic Agents Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medical Liquid Embolic Agents Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medical Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medical Liquid Embolic Agents Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medical Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medical Liquid Embolic Agents Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Medical Liquid Embolic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Medical Liquid Embolic Agents Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Medical Liquid Embolic Agents Revenue by Region
- 7.1 Global Medical Liquid Embolic Agents Revenue by Region
- 7.1.1 Global Medical Liquid Embolic Agents Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Medical Liquid Embolic Agents Revenue by Region (2021-2026)
- 7.1.3 Global Medical Liquid Embolic Agents Revenue by Region (2027-2032)
- 7.1.4 Global Medical Liquid Embolic Agents Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Medical Liquid Embolic Agents Revenue (2021-2032)
- 7.2.2 North America Medical Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Medical Liquid Embolic Agents Revenue (2021-2032)
- 7.3.2 Europe Medical Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Medical Liquid Embolic Agents Revenue (2021-2032)
- 7.4.2 Asia-Pacific Medical Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Medical Liquid Embolic Agents Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Medical Liquid Embolic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BlackSwan Vascular
- 8.1.1 BlackSwan Vascular Company Information
- 8.1.2 BlackSwan Vascular Business Overview
- 8.1.3 BlackSwan Vascular Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BlackSwan Vascular Medical Liquid Embolic Agents Product Portfolio
- 8.1.5 BlackSwan Vascular Recent Developments
- 8.2 Success Bio-Tech
- 8.2.1 Success Bio-Tech Company Information
- 8.2.2 Success Bio-Tech Business Overview
- 8.2.3 Success Bio-Tech Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Success Bio-Tech Medical Liquid Embolic Agents Product Portfolio
- 8.2.5 Success Bio-Tech Recent Developments
- 8.3 Johnson & Johnson
- 8.3.1 Johnson & Johnson Company Information
- 8.3.2 Johnson & Johnson Business Overview
- 8.3.3 Johnson & Johnson Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Johnson & Johnson Medical Liquid Embolic Agents Product Portfolio
- 8.3.5 Johnson & Johnson Recent Developments
- 8.4 Medtronic
- 8.4.1 Medtronic Company Information
- 8.4.2 Medtronic Business Overview
- 8.4.3 Medtronic Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Medtronic Medical Liquid Embolic Agents Product Portfolio
- 8.4.5 Medtronic Recent Developments
- 8.5 Meril Life
- 8.5.1 Meril Life Company Information
- 8.5.2 Meril Life Business Overview
- 8.5.3 Meril Life Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Meril Life Medical Liquid Embolic Agents Product Portfolio
- 8.5.5 Meril Life Recent Developments
- 8.6 Balt Group
- 8.6.1 Balt Group Company Information
- 8.6.2 Balt Group Business Overview
- 8.6.3 Balt Group Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Balt Group Medical Liquid Embolic Agents Product Portfolio
- 8.6.5 Balt Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Liquid Embolic Agents Value Chain Analysis
- 9.1.1 Medical Liquid Embolic Agents Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Liquid Embolic Agents Production Mode & Process
- 9.2 Medical Liquid Embolic Agents Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Liquid Embolic Agents Distributors
- 9.2.3 Medical Liquid Embolic Agents Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst